To mechanistically assess the ability of aspirin to delay primary tumour growth, we studied the induction of autophagy within a cohort (N = 3 per group) of resected primary trastuzumab‐resistant HCC1954 Her2+ tumours treated daily with 30 mg/kg aspirin,120 mg/kg aspirin or vehicle. The gene discussed is ERBB2; the disease is neoplasm.